Fentanyl

PRISCILLA PRESLEY HONORED AT VICTORIA'S VOICE FOUNDATION MUSIC FOR LIFE GALA HEADLINED BY "GODMOTHER OF SOUL" PATTI LABELLE

Retrieved on: 
Tuesday, November 14, 2023
Naloxone, Courage, Human, Fentanyl, Business development, Food, Human voice, Victoria's Voice Foundation 200, Drug overdose, Music, Legacy Award, Dance, Death, Oxycodone, Fear, Heroin, ONDCP, CDC, DEA, ILG, Inc., Serious Request, Consciousness, Cereal, Auction

ORLANDO, Fla., Nov. 14, 2023 /PRNewswire/ -- Priscilla Presley was honored at Victoria's Voice Foundation gala "Music for Life" on November 11, receiving the 2023 Legacy Award for her courage and grace amidst adversity. Presley, a best-selling author, actress and executive producer of the critically acclaimed feature film, "Priscilla," received the award in front of nearly 300 attendees from Jackie Siegel, the co-founder of Victoria's Voice.

Key Points: 
  • Special Evening in Palm Island, Florida Raised Funds to Fight Opioid Crisis
    ORLANDO, Fla., Nov. 14, 2023 /PRNewswire/ -- Priscilla Presley was honored at Victoria's Voice Foundation gala "Music for Life" on November 11, receiving the 2023 Legacy Award for her courage and grace amidst adversity.
  • Presley, a best-selling author, actress and executive producer of the critically acclaimed feature film, "Priscilla," received the award in front of nearly 300 attendees from Jackie Siegel, the co-founder of Victoria's Voice.
  • Victoria's Voice provides drug prevention education and naloxone awareness, support and resources to those affected by substance use.
  • For photos from the Music for Life Gala, click here .

Consumer Watchdog Calls on Medical Board to Comply with Consumer Protection Law Ahead of Resurrection of Substance Abusing Physicians Program

Retrieved on: 
Tuesday, November 14, 2023
Arm, California Franchise Tax Board, Interim order, Fentanyl, Medical Board of California, Substance abuse, Interim, Legislation, Risk, Public key certificate, Patient, Multimedia, Medicine, Uniform, Health, Morphine, Ventura County Star, Health care, Consumer Watchdog, Physician, Ventura County, California, Letter, Nursing, Pharmaceutical industry, Medical device

The Uniform Standards give the Medical Board the consumer protection tools it needs to monitor substance abusing physicians.

Key Points: 
  • The Uniform Standards give the Medical Board the consumer protection tools it needs to monitor substance abusing physicians.
  • Consumer Watchdog sent the Medical Board of California a letter with recommended changes to the PHWP program regulations.
  • The PHWP was created by legislation for the Medical Board to refer doctors or doctors can self-refer for treatment.
  • The Medical Board of California voted to unanimously terminate its confidential physician diversion program for substance abusing and mentally ill physicians in 2008.

Arkansas Children's Establishes $70 Million Groundbreaking Center Focused on Opioids' Impact on Children

Retrieved on: 
Thursday, November 9, 2023
Arkansas Department of Health, Arkansas Children's Hospital, Brain, ESC, Research, Opioid, Fentanyl, NICU, Pediatrics, USDA, Substance abuse, Toxicology, Arkansas Department of Corrections, Learning, Informatics, History, Pregnancy, Journal, Map, Machine learning, Poisoning, Heroin, Health, Child, Birth, NCOR, School, Mother, Alcohol withdrawal syndrome, Social work, Hospital, The Journal of Pediatrics, Fetus, ROCK, Initiative, Face, Research institute, Pharmaceutical industry, Vaccine, Nursing, Birth control

LITTLE ROCK, Ark., Nov. 9, 2023 /PRNewswire/ -- Arkansas Attorney General Tim Griffin is awarding $50 million of opioid settlement funds to Arkansas Children's to pioneer one of the nation's most ambitious research efforts dedicated to opioids' impact on children.

Key Points: 
  • I am granting $50 million of the state's opioid settlement funds to help establish the National Center for Opioid Research & Clinical Effectiveness (NCOR) at Arkansas Children's.
  • "This research center will be the first of its kind not just in Arkansas, but in the entire country.
  • "By creating this center, we are accelerating a healthier future for the children of Arkansas.
  • Scientists will work closely with the Arkansas Children's Research Institute and Arkansas Children's Nutrition Center, one of six National Human Nutrition Centers funded through the USDA-ARS.

AltaPointe's Behavioral Health Crisis Center Offers Innovative Approach to Fentanyl Addiction Treatment Using Ketamine in Combination with Buprenorphine

Retrieved on: 
Thursday, November 9, 2023
BHCC, Buprenorphine, Ketamine, Heroin, Patient, Fentanyl, Chronic pain, Pharmaceutical industry, Cereal, Buprenorphine/naloxone

MOBILE, Ala., Nov. 8, 2023 /PRNewswire-PRWeb/ -- In the ongoing battle against the fentanyl epidemic, a promising new approach has emerged and AltaPointe Health is at the forefront. AltaPointe's Behavioral Health Crisis Center (BHCC) has started offering the use of ketamine to help transition a patient from fentanyl to buprenorphine (often referred to by the common brand name Suboxone), a proven addiction-treatment medicine.

Key Points: 
  • In the ongoing battle against the fentanyl epidemic, a promising new approach has emerged and AltaPointe Health is at the forefront.
  • AltaPointe's Behavioral Health Crisis Center (BHCC) has started offering the use of ketamine to help transition a patient from fentanyl to buprenorphine (often referred to by the common brand name Suboxone), a proven addiction-treatment medicine.
  • MOBILE, Ala., Nov. 8, 2023 /PRNewswire-PRWeb/ -- In the ongoing battle against the fentanyl epidemic, a promising new approach has emerged and AltaPointe Health is at the forefront.
  • AltaPointe's Behavioral Health Crisis Center (BHCC) has started offering the use of ketamine to help transition a patient from fentanyl to buprenorphine (often referred to by the common brand name Suboxone), a proven addiction-treatment medicine.

Fentanyl.org Launches Platform Providing Real Time Help - Get Reliable Information About Fentanyl & Synthetic Opioids Comprehensive Directory of Treatment & Opiate Detox Options

Retrieved on: 
Wednesday, November 8, 2023
Opioid, Parent, Morphine, DEA, Heroin, Skin, Death, Oxycodone, Drug, Fentanyl, Adderall

COMMACK, N.Y., Nov. 8, 2023 /PRNewswire/ -- Fentanyl kills more people in the USA than have died in wars. It is so deadly that even inhaling it can cause death First responders have died from coming into contact with it, as it is easily absorbed through the skin. Fentanyl comes into the USA from the land, sea and air borders. The nations youth are dying in record numbers from Fentanyl Laced counterfeit street drugs.

Key Points: 
  • Over 300 Americans die every day from overdoses related to synthetic opioids like fentanyl.
  • Fentanyl is a synthetic opioid that is up to 50X stronger than heroin and 100X stronger than morphine.
  • Fentanyl is commonly used to create counterfeit drugs sold on the street as OxyContin, Xanax, Adderall, and other pills.
  • In 2022, the DEA seized more than 58.3 million pills containing fentanyl and more than 13,000 pounds of fentanyl powder.

Soul Tribes International Ministries Files $1 Billion Lawsuit Against the City of Detroit and Detroit Police Department

Retrieved on: 
Thursday, November 2, 2023
Psilocybin, Sacraments of the Catholic Church, Religious Land Use and Institutionalized Persons Act, Michigan Court of Appeals, Religion, State, Police, City, Plague, Federal, Fentanyl, Spirituality, Ground substance, Detroit Police Department, Nightclub, Cannabis, Church

Last month, the City of Detroit raided and filed a baseless and discriminatory nuisance lawsuit against Soul Tribes and its members for engaging in dispensing its Holy Sacrament, Sacred (Psilocybin) Mushrooms" to its membership.

Key Points: 
  • Last month, the City of Detroit raided and filed a baseless and discriminatory nuisance lawsuit against Soul Tribes and its members for engaging in dispensing its Holy Sacrament, Sacred (Psilocybin) Mushrooms" to its membership.
  • After an onerous search and much consideration, Soul Tribes International Ministries chose to retain the law firm "Cannabis Counsel," a distinguished Detroit law firm specializing in the compliance and legality of Cannabis and other controlled substances.
  • The City of Detroit has not yet responded to the lawsuit.
  • Soul Tribes International Ministries remains steadfast in their pursuit of a resolution that safeguards their religious liberty, ensuring that psychedelic/entheogen-based religious practices, as guaranteed in our Constitutions and laws, are upheld and protected indefinitely.

BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (sublingual dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)

Retrieved on: 
Monday, November 6, 2023
Post-traumatic stress disorder, FDA, Yale School of Medicine, Opioid use disorder, Standard of care, Intelligence, Government, Public Health Service Act, White House, Dexmedetomidine, Opioid epidemic, BID, Federal Food, Drug, and Cosmetic Act, Federation, Addiction, Xylazine, Psychiatry, COWS, Recreational drug use in Kenya, Locus coeruleus, Pharmacokinetics, OUD, National Institute on Drug Abuse, NIDA, Columbia University, NIH, Safety, Public, American Journal, Minneapolis Veterans Affairs Health Care System, Therapy, Office of Inspector General, U.S. Department of Health and Human Services, Patient, Fentanyl, Bangladesh Technical Education Board, RTI International, United States Public Health Service, Pharmaceutical industry, Neuroscience

NEW HAVEN, Conn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced an update on the National Institute on Drug Abuse (NIDA)-funded trial evaluating BXCL501 (sublingual dexmedetomidine) as a potential treatment for opioid use disorder (OUD).

Key Points: 
  • NIDA has requested Columbia University, the trial coordinator, to add a fourth site to target trial completion in 2024.
  • After this time, BioXcel Therapeutics plans to seek FDA feedback on potential registrational paths.
  • “With BXCL501, we are excited about the potential to treat patients who are physically dependent on illicit and prescription opioids.
  • In addition to OUD as an indication, BioXcel Therapeutics has been awarded key opportunities for the development of BXCL501 in post-traumatic stress disorder and alcohol use disorder.

CORRECTION: National Youth Prevention Summit Highlights Colorado Campaign to Protect Teens from Fentanyl

Retrieved on: 
Friday, November 3, 2023
Science, Crossing Bayabas National High School, Anti-Drug Abuse Act of 1988, SE2, Health, Human, Behavior, Congress, Organization, Naloxone, Research, Friends, HIDTA, Norm (mathematics), Statistics, Walking, ADAPT, Anderson, Fentanyl, Communication, Parent, Birth control, Property management

Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) -- A national youth prevention summit organized by the National High Intensity Drug Trafficking Areas (HIDTA) Program in October highlighted Colorado’s new youth fentanyl prevention campaign, which uses the power of positive social norms to limit pill misuse by adolescents.

Key Points: 
  • Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) -- A national youth prevention summit organized by the National High Intensity Drug Trafficking Areas (HIDTA) Program in October highlighted Colorado’s new youth fentanyl prevention campaign, which uses the power of positive social norms to limit pill misuse by adolescents.
  • That included surveys of youth and parents, focus groups, and engagement with youth organizations like Rise Above Colorado, which served as a partner in the campaign.
  • It highlights, among other statistics, that 87% of Colorado teens would act to protect their friends from pills that could contain fentanyl.
  • Recordings of the full summit, including the presentation on the Colorado campaign and related materials, can be accessed at ADAPT’s website .

National Youth Prevention Summit Highlights Colorado Campaign to Protect Teens from Fentanyl

Retrieved on: 
Friday, November 3, 2023
Science, Crossing Bayabas National High School, Anti-Drug Abuse Act of 1988, SE2, Health, Human, Behavior, Congress, Organization, Naloxone, Research, Friends, HIDTA, Norm (mathematics), Statistics, Walking, ADAPT, Anderson, Fentanyl, Communication, Parent, Birth control, Property management

Denver, Colorado, Nov. 02, 2023 (GLOBE NEWSWIRE) -- A national youth prevention summit organized by the National High Intensity Drug Trafficking Areas (HIDTA) Program in October highlighted Colorado’s new youth fentanyl prevention campaign, which uses the power of positive social norms to limit pill misuse by adolescents.

Key Points: 
  • Denver, Colorado, Nov. 02, 2023 (GLOBE NEWSWIRE) -- A national youth prevention summit organized by the National High Intensity Drug Trafficking Areas (HIDTA) Program in October highlighted Colorado’s new youth fentanyl prevention campaign, which uses the power of positive social norms to limit pill misuse by adolescents.
  • That included surveys of youth and parents, focus groups, and engagement with youth organizations like Rise Above Colorado, which served as a partner in the campaign.
  • It highlights, among other statistics, that 87% of Colorado teens would act to protect their friends from pills that could contain fentanyl.
  • Recordings of the full summit, including the presentation on the Colorado campaign and related materials, can be accessed at ADAPT’s website .

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen

Retrieved on: 
Friday, October 27, 2023
Drug, Adderall, Workplace, PCP, Organization, Cocaine, Fentanyl, Amphetamine, Education minister, Pharmaceutical industry, Psychemedics Corporation

Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.

Key Points: 
  • Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.
  • Traditional 5-panel drug tests, rooted in a four-decade-old paradigm, have failed to evolve in today’s drug market and are unable to detect the rising drug, fentanyl.
  • The Advanced 5-Panel Drug Screen epitomizes this legacy, offering clients a cost-effective choice to adapt their testing protocols in sync with evolving priorities and employment policies.
  • The Advanced 5-Panel Drug Screen is crafted to focus exclusively on these critical threats, ensuring the highest level of security for organizations.